ATHERSYS, INC / NEW
Healthcare · Pharmaceutical Preparations · DE · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | |
|---|---|---|---|---|---|---|
| Revenue | $5.3M | $5.5M | $1.4M | $5.6M | $1.1M | $1.5M |
| Operating income | −$77.0M | −$87.1M | −$78.3M | −$45.5M | −$10.3M | −$6.4M |
| Net income | −$72.5M | −$87.0M | −$78.8M | −$44.6M | −$10.2M | −$5.6M |
| Total assets | $27.7M | $60.2M | $59.7M | $41.7M | $61.7M | $33.6M |
| Total liabilities | — | — | — | — | — | — |
| Equity | −$23.9M | $16.4M | $31.4M | $23.3M | $43.1M | $23.4M |
| EPS (diluted) | $-6.07 | $-9.69 | $-10.50 | $-0.29 | — | $-0.06 |
| Shares out. | 244.0M | 215.2M | 164.1M | 146.8M | 125.8M | 109.8M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2022- Operating margin
- −1446.2%
- Net margin
- −1362.1%
- Return on equity
- 304.1%
- Return on assets
- −261.6%
- Return on capital (ROCE)
- —
- Liabilities / assets
- —
- Debt / equity
- —
- Book value / share
- $-0.10
- Revenue growth (YoY)
- −3.4%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2022- Accruals / assets
- −49.0%clean
- Piotroski F-Score
- 3/8weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 2 severe● 4 warning● 2 good- Negative shareholder equity
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Operating losses (negative operating margin)
- Reported a net loss
- Revenue declined year-over-year
- Negative operating cash flow
- Strong return on equity (>15%)
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Kmissed a reporting deadline ↗Apr 1, 2024
- NT 10-Qmissed a reporting deadline ↗Nov 14, 2023
- NT 10-Qmissed a reporting deadline ↗Aug 15, 2023
- NT 10-Kmissed a reporting deadline ↗Apr 3, 2023
- NT 10-Qmissed a reporting deadline ↗Aug 14, 2007
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
Material events
SEC Form 8-K · most recent- Entered a material agreement · Completed an acquisition or disposition · Director / officer change · Regulation FD disclosureApr 5, 2024
- Entered a material agreement · Bankruptcy or receivership · New financial obligation · Regulation FD disclosureJan 8, 2024
- Costs from exit or disposal · Director / officer changeDec 22, 2023
- Entered a material agreement · Unregistered equity saleOct 30, 2023
- Delisting / listing-standard notice · Other material eventOct 18, 2023
- Entered a material agreement · Unregistered equity saleOct 12, 2023
- Entered a material agreement · Other material eventOct 11, 2023
- Other material eventOct 3, 2023
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- 8-KFORM 8-KApr 5, 2024
- NT 10-KFORM NT 10-KApr 1, 2024
- 8-KFORM 8-KJan 8, 2024
- 25-NSEDec 27, 2023
- 8-KFORM 8-KDec 22, 2023
- 4HANSEN, MAIA FORM 4 2023.12.18Dec 21, 2023
- 424B3FORM 424B3Dec 4, 2023
- EFFECTNov 29, 2023
- CORRESPNov 28, 2023
- S-1/AFORM S-1/ANov 22, 2023
- 10-QFORM 10-QNov 16, 2023
- UPLOADNov 15, 2023
- NT 10-QFORM NT 10-QNov 14, 2023
- S-1FORM S-1Nov 9, 2023
- 8-KFORM 8-KOct 30, 2023